China NMPA Product Recall - Total Hip System

MicroPort Orthopedics, Inc., in cooperation with its distributor, Shanghai MicroPort Orthopedic Medical Technology Co., Ltd., issued a global voluntary recall for components of its Total Hip System. This action was officially reported by the National Medical Products Administration (NMPA) on March 17, 2017. The recall was prompted by a critical manufacturing defect where the "BIOLOX FORTE 36mm Ceramic Femoral Head" component was found to be approximately 2mm shorter than the MicroPort 36mm Cobalt Chrome and Biolox DELTA Ceramic femoral heads. This dimensional inconsistency creates a risk of joint laxity and/or dislocation, potentially necessitating additional revision surgery for patients. The issue was initially reported by the company on February 24, 2017, with the supervisory department documenting the recall on March 6, 2017. While the recall is global, comprehensive checks of import records confirmed that the affected product was not sold or distributed within China. Nonetheless, the NMPA directed local food and drug administrations to enhance their supervision and management of similar medical devices to maintain product integrity and patient safety.